New treatment to slow muscle wastage in boys with DMD
A medicine developed by EU-funded researchers has been approved to treat children with the degenerative and fatal genetic disease Duchenne muscular dystrophy. A major clinical trial is expected to announce positive results soon.
Source: EUROPA - Research Information Centre - Category: Research Source Type: news
More News: Boys | Children | Clinical Trials | Genetics | Muscular Dystrophy | Reflex Sympathetic Dystrophy | Research